Lowering mTORC1 drives CAR T-cells home in acute myeloid leukemia

Research output: Contribution to journalArticlepeer-review

3 Scopus citations

Abstract

Cellular therapies have demonstrated limited efficacy thus far in acute myeloid leukemia (AML). A recent study shows that mTOR complex 1 activation downregulated CXCR4 reducing marrow infiltration of EpCAM-targeting chimeric antigen receptor (CAR) T-cells in AML. Abrogating mTOR signaling by cotreatment with mTOR inhibitors during IL2-mediated ex vivo expansion upregulated CXCR4 and bolstered bone marrow migration and AML elimination by CAR T-cells.

Original languageEnglish (US)
Pages (from-to)5739-5741
Number of pages3
JournalClinical Cancer Research
Volume27
Issue number21
DOIs
StatePublished - Nov 15 2021

ASJC Scopus subject areas

  • Oncology
  • Cancer Research

Fingerprint

Dive into the research topics of 'Lowering mTORC1 drives CAR T-cells home in acute myeloid leukemia'. Together they form a unique fingerprint.

Cite this